- Home
- DELL vs LLY Comparison
DELL vs LLY Comparison
Compare DELL & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DELL | LLY |
|---|---|---|
| Founded | 1984 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.7B | 1.0T |
| IPO Year | 2013 | 2007 |
Fundamental Metrics
Financial Performance| Metric | DELL | LLY |
|---|---|---|
| Price | $424.50 | $1,107.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | $181.63 | ★ $1,218.84 |
| AVG Volume (30 Days) | ★ 9.8M | 2.4M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.23% | 0.81% |
| EPS Growth | 36.05 | ★ 95.99 |
| EPS | 5.24 | ★ 8.26 |
| Revenue | ★ $113,538,000,000.00 | $65,179,000,000.00 |
| Revenue This Year | $26.19 | $27.15 |
| Revenue Next Year | $8.60 | $16.04 |
| P/E Ratio | ★ $77.15 | $135.88 |
| Revenue Growth | 18.80 | ★ 44.70 |
| 52 Week Low | $110.22 | $623.78 |
| 52 Week High | $469.47 | $1,182.73 |
Technical Indicators
Market Signals| Indicator | DELL | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 67.21 | 57.53 |
| Support Level | $126.13 | $1,032.70 |
| Resistance Level | $469.47 | $1,165.92 |
| Average True Range (ATR) | 30.51 | 34.45 |
| MACD | -3.29 | -4.64 |
| Stochastic Oscillator | 54.75 | 46.53 |
Price Performance
Historical ComparisonAbout DELL Dell Technologies Inc.
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.